These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1103241)

  • 21. Review of human renal transplantation at the Toronto General Hospital.
    Farrow GA; Wilson DR; Fenton SS; Hayman WP
    Can J Surg; 1973 Mar; 16(2):134-8. PubMed ID: 4570266
    [No Abstract]   [Full Text] [Related]  

  • 22. Supplemental report on thoracic duct drainage for immunosuppression.
    Fish J
    Transplant Proc; 1972 Dec; 4(4):467. PubMed ID: 4566788
    [No Abstract]   [Full Text] [Related]  

  • 23. Methyl prednisolone in the treatment of renal transplant rejection.
    Clarke AG; Salaman JR
    Clin Nephrol; 1974; 2(6):230-4. PubMed ID: 4141287
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of organ specificity in renal allograft enhancement with F(ab') 2 fragments.
    Shaipanich T; Wren S; von Haefen U; Koppenheffer T; Busch G; Wilson RE
    Transplant Proc; 1973 Mar; 5(1):581-3. PubMed ID: 4572116
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of medroxyprogesterone and corticosteroids in the treatment of canine renal allografts.
    Macdonald AS; Falvey CF; Chan CC
    Can J Surg; 1972 Sep; 15(5):326-31. PubMed ID: 4560407
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM; Pirsch JD; Melzer JS; Sollinger HW; Kalayoglu M; Reed A; Knechtle SJ; Belzer FO
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract]   [Full Text] [Related]  

  • 27. Simultaneous homotransplantation of heart and kidney from the same donor in bilaterally nephrectomized dogs.
    Legrain M; Gandjbakhch ; Dubois M; Wajcner G; Rottembourg J; Guilmet D
    Transplant Proc; 1969 Mar; 1(1):293-5. PubMed ID: 4944230
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring of renal allografts under immunosuppression.
    Hammer C
    Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):340-2. PubMed ID: 3548110
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperacute rejection of renal allografts in the primate: protective effect of F(ab') 2 fragment of hyperimmune serum.
    Kobayashi K; Hricko GM; Habal MB; Lukl P; Busch GJ; Hunsicker L; Reisner GS; Birtch AG
    Transplantation; 1972 Sep; 14(3):374-81. PubMed ID: 4629283
    [No Abstract]   [Full Text] [Related]  

  • 31. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
    Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of immunosuppression on the prevalence of aseptic bone necrosis after renal transplantation.
    Cotorruelo JG; De Francisco AL; Canga E; Amado JA; Riancho JA; De Bonis E; Zubimendi JA; Ruiz JC; Sanz de Castro S; Arias M
    Transplant Proc; 1991 Aug; 23(4):2199-200. PubMed ID: 1871842
    [No Abstract]   [Full Text] [Related]  

  • 33. Posttransplant renal allograft dysfunction as a prognostic factor in triple therapy-treated patients.
    Pallardó LM; García J; Sánchez J; Górriz JL; Orero E; Calabuig F
    Transplant Proc; 1992 Feb; 24(1):113-4. PubMed ID: 1539199
    [No Abstract]   [Full Text] [Related]  

  • 34. Passive enhancement of cadaver renal allografts: a prospective randomized trial of F(ab')2 therapy.
    Wilson RE; Garovoy MR; Strom TB; Lowry RP; Busch GJ; Vineyard GC; Tilney NL
    Transplant Proc; 1981 Mar; 13(1 Pt 1):531-2. PubMed ID: 7022888
    [No Abstract]   [Full Text] [Related]  

  • 35. Verrucous carcinoma in a reanl transplant patient after long-term immunosuppression.
    Turner JE; Hodge SJ; Callen JP
    Arch Dermatol; 1980 Sep; 116(9):1074-6. PubMed ID: 6998379
    [No Abstract]   [Full Text] [Related]  

  • 36. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 37. Results of the kidney transplantation in the Warsaw Center.
    Nielubowicz J; Orlowski T; Wesolowski S; Falda Z; Gradowska L; Rowińska D; Rowiński W; Skośkiewicz M; Szostek M; Filipowicz Z; Glyda J; Goliszek Z; Jedrzejewski R; Kardasiewicz W; Klepacka J; Klopotowska E; Kossowska B; Koziak H; Krzywicka E; Lao M; Ladygin J; Marzinek B; Miller J; Michalowicz B; Machowski Z; Olszewski K
    Pol Med J; 1971; 10(2):340-3. PubMed ID: 4104328
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 39. The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts.
    Halpern B; Cachera JP; Lacombe M; Hathaway A; Crepin Y; Hung BM; Lacassagne JP; Leandri J; Laurent D; Dubost C; de Mendoza M
    Transplant Proc; 1969 Mar; 1(1):467-9. PubMed ID: 4944261
    [No Abstract]   [Full Text] [Related]  

  • 40. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.